Drugs / NBP6081
last change Mar 2013 re-read 2 minutes ago

NBP6081

Developed for
varicella zoster infection
Investigated by
SK Chemicals Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03121638 Nov 2012 → Feb 2013 varicella zoster infection SK Chemicals Co., Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as NBP6081 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03121638